Previous Article | Next Article 
Journal of Clinical Microbiology, February 1999, p. 445-446, Vol. 37, No. 2
Infectious Diseases Section, Medical Service,
VA Medical Center, and Department of Medicine, Boston University School
of Medicine, Boston, Massachusetts1;
Laboratory of Microbiology and Pathology, Queensland
Health, Brisbane, Australia2; and
Laboratory of Host Defenses, National Institutes of Allergy
and Infectious Diseases, National Institutes of Health, Bethesda,
Maryland3
Received 28 May 1998/Returned for modification 7 July 1998/Accepted 9 November 1998
Isolates of the Mycobacterium avium complex were
examined for hemolysin expression. Only invasive isolates of M. avium were observed to be hemolytic (P < 0.001), with activity the greatest for isolates of serovars 4 and 8. Thus, M. avium hemolysin appears to represent a virulence
factor necessary for invasive disease.
Organisms of the Mycobacterium
avium complex (MAC) are infrequent pathogens of humans. Among
immunocompetent hosts, MAC primarily represents a respiratory pathogen,
especially for individuals with chronic obstructive pulmonary disease,
and may cause pulmonary fibrosis or cavitary lung disease (1, 5,
12). In contrast, among immunosuppressed individuals with human
immunodeficiency virus (HIV) infection (2, 10) and CD4
lymphopenia (4), disseminated infection with MAC is common.
However, numerous studies have suggested a role for expressed
mycobacterial products in the pathogenesis of infection. We have
previously shown that M. avium expresses a
magnesium-dependent, cell wall-associated hemolysin (9) and
reported on the partial purification of this protein (8).
Analogous to Listeria monocytogenes (11), we
postulated that hemolysin expression by M. avium is necessary for intracellular survival. In this report, the epidemiology of hemolysin expression is described for invasive and noninvasive isolates of MAC.
(This study was presented in part at the 32nd Annual Meeting,
Infectious Diseases Society of America, Orlando, Fla., 7 to 9 October
1994.)
Invasive isolates of MAC (n = 28) included 19 isolates
of M. avium and 2 isolates of M. intracellulare cultured from individuals with AIDS (1a)
and 4 isolates of M. avium and 3 isolates of MAC X
cluster (3) cultured from HIV-seronegative patients
(4). Respiratory isolates (n = 32) included
12 isolates of M. avium and 15 isolates of
M. intracellulare cultured from elderly individuals and
3 isolates of M. avium and 2 isolates of M. intracellulare from immunosuppressed patients (4).
HIV-seronegative patients met the American Thoracic Society criteria
for pulmonary mycobacterial disease (1). Insufficient
clinical data was available for the group of isolates cultured from
elderly patients to apply these criteria; however, in many cases
individuals had repeatedly positive sputa.
While false-positive samples cannot be absolutely excluded, all initial
patient samples were inoculated onto solid media, which limits
cross-contamination. Moreover, many patients had multiple positive
cultures yielding the same strain by pulsed-field gel
electrophoresis (14, 15). Pulsed-field gel electrophoresis analysis showed that each of the isolates described above represented different strains.
In prior studies, we identified clusters of patients infected with
common strains of MAC (14, 15). Four additional isolates from these clusters and the environmental (potable hot water) source
isolate for one cluster (15) were also analyzed.
Organisms were inoculated into 7H9 broth, incubated at 37°C to an
absorbance at 600 nm (A600) of 0.2, washed once
with Alsever's solution (75 mM NaCl, 25 mM sodium citrate, 110 mM
glucose, pH 6.1), resuspended in Alsever's solution to 5 × 109 CFU/ml, and immediately assayed.
Hemolysis was determined in triplicate in 5-ml sterile, polystyrene
snap-top tubes (USA Scientific, Ocala, Fla.) containing 3 ml of
Alsever's solution; 10 mM CaCl2; 10 mM MgSO4;
25 µl of washed, defibrinated sheep erythrocytes (Adams Scientific,
West Warwick, R.I.); and 5 × 107 CFU of mycobacteria.
Sample tubes were incubated for 6 h at 37°C and then gently
mixed, and the erythrocytes were pelleted (700 × g for
10 min). The A520 of 1 ml of supernatant was
determined spectrophotometrically (Spectronic 1001 spectrophotometer;
Bausch and Lomb, Rochester, N.Y.) in glass cuvettes. Tubes containing either no bacteria or the prototype hemolytic strain 920A-7 were included as negative and positive controls, respectively. Hemolysis was
defined as a net absorbance above 0.045: 0.045 to 0.060 was considered
weakly hemolytic, 0.061 to 0.080 was considered moderately hemolytic,
and >0.080 was considered strongly hemolytic.
The range of hemolysis for individual isolates typically yielded
standard deviations of Except for some isolates (14, 15), serotyping was performed
at the Laboratory of Microbiology and Pathology, Queensland Health,
Brisbane, Australia.
Of the 23 isolates of M. avium causing disseminated
disease, 14 (61%) were hemolytic (Table
1). The frequencies of hemolysis were
similar for isolates cultured from individuals with or without AIDS. In
contrast, only 1 (7%) of 15 M. avium respiratory
isolates was hemolytic (P < 0.001, Fischer's exact
test). None of the 19 isolates of M. intracellulare
were hemolytic (P < 0.001, Fischer's exact test). One
of three isolates of MAC X cluster was hemolytic.
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Hemolysin as a Virulence Factor for Systemic
Infection with Isolates of Mycobacterium avium
Complex
ABSTRACT
Top
Abstract
Text
References
TEXT
Top
Abstract
Text
References
5% (data not shown). Day-to-day variations were not greater than 10% (data not shown).
TABLE 1.
Expression of hemolysin by clinical isolates of MAC
For 34 (91%) isolates of M. avium, the serovar was
determined (Table 2). Serovars 1, 4, and
8 predominated among both invasive and pulmonary strains, representing
60 and 64% of typed strains, respectively. Only isolates of serovar 4 or 8 expressed moderate or strong hemolysis, whereas other serovars
expressed weak or no hemolysis (P < 0.001).
|
To determine the consistency of hemolysin expression, isolates of M. avium representing the same strain from different patients were analyzed. For one pair of isolates, both isolates were strongly hemolytic, and for a second pair, both were nonhemolytic. For a third cluster of three isolates, two were strongly hemolytic and one was nonhemolytic; the matching environmental strain was also strongly hemolytic.
We found a statistically significant association between disseminated infection and hemolysin expression by M. avium. Moreover, this observation was independent of the host immune status. While hemolysin expression was not universal among invasive isolates, host factors such as gastrointestinal mucosal defects and severe immunosuppression may have allowed less virulent organisms to gain entry to the bloodstream and cause disease.
The fact that no isolate of M. intracellulare was hemolytic may represent a true difference in pathogenicity between M. avium and M. intracellulare consistent with the observation that >95% of invasive isolates of MAC represent M. avium (5, 13).
The mode of action of hemolysin on mammalian membranes is unknown; however, in other bacteria phospholipase may exhibit cytolytic activity. Genes encoding phospholipase C and phospholipase D cloned from M. tuberculosis (6) conferred a hemolytic phenotype to Escherichia coli (6). However, homologous DNA was not present in M. avium (6, 7). Whether M. avium hemolysin exhibits phospholipase activity is currently under investigation.
Thus, our data suggests that hemolysin expression by M. avium may have a role in the pathogenesis of invasive disease. The observation that hemolysin expression was greatest for isolates of serovar 4 or 8 is of interest, considering the overrepresentation of these serovars in disseminated disease, and may represent clonal segregation of this putative virulence factor.
| |
ACKNOWLEDGMENTS |
|---|
This work was supported in part by the Medical Research Service, Department of Veterans Affairs.
Alexander Sloutsky is acknowledged for many helpful discussions. C. Fordham von Reyn and the Mycobacteriology Section of the Massachusetts State Laboratory, Boston, are acknowledged for their generous gifts of bacterial isolates.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Research Service (151), VA Medical Center, 150 South Huntington Ave., Boston, MA 02130. Phone: (617) 232-9500, ext. 5576. Fax: (617) 278-4540. E-mail: maslow.joel_n.md{at}boston.va.gov.
| |
REFERENCES |
|---|
|
Top
Abstract
Text
References
|
|---|
| 1. | American Thoracic Society. 1997. Diagnosis and treatment of disease caused by nontuberculous mycobacteria. Am. J. Respir. Crit. Care Med. 156:S1-S25. |
| 1a. | Arbeit, R. D., A. Slutsky, T. W. Barber, J. N. Maslow, S. Niemczyk, J. O. Falkinham III, G. T. O'Conner, and C. F. von Reyn. 1993. Genetic diversity among strains of Mycobacterium avium causing monoclonal and polyclonal bacteremia in patients with AIDS. J. Infect. Dis. 167:1384-1390[Medline]. |
| 2. | Benson, C. A. 1994. Disease due to Mycobacterium avium complex in patients with AIDS: epidemiology and clinical syndromes. Clin. Infect. Dis. 18:S218-S222. |
| 3. | Cregan, P., D. M. Yajko, V. L. Ng, P. C. Gonzalez, P. S. Nassos, C. A. Saunders, and W. Hadley. 1992. Use of DNA probes to detect Mycobacterium intracellulare and "X" mycobacteria among clinical isolates of Mycobacterium avium complex. J. Infect. Dis. 166:191-194[Medline]. |
| 3a. | Dawson, D. Unpublished data. |
| 4. |
Holland, S.,
E. Eisenstein,
D. Kuhns,
M. Turner,
T. Fleisher,
W. Strober, and J. Gallin.
1994.
Treatment of refractory disseminated nontuberculous mycobacterial infection with interferon gamma.
N. Engl. J. Med.
330:1348-1355 |
| 5. | Horsburgh, C. R., Jr., U. G. Mason III, D. C. Farhi, and M. D. Iseman. 1985. Disseminated infection with Mycobacterium avium-intracellulare: a report of 13 cases and a review of the literature. Medicine 64:36-48[Medline]. |
| 6. | Johansen, K. A., R. E. Gill, and M. L. Vasil. 1996. Biochemical and molecular analysis of phospholipase C and phospholipase D activity in mycobacteria. Infect. Immun. 64:3259-3266[Abstract]. |
| 7. | Leão, S. C., C. L. Rocha, L. A. Murillo, C. A. Parra, and M. E. Patarroyo. 1995. A species-specific nucleotide sequence of Mycobacterium tuberculosis encodes a protein that exhibits hemolytic activity when expressed in Escherichia coli. Infect. Immun. 63:4301-4306[Abstract]. |
| 8. | Maslow, J., E. Carlin, and J. Belisle. 1998. Purification of a M. avium hemolysin: a putative virulence factor for invasive disease, abstr. 429. In Abstracts of the Keystone Symposium on Tuberculosis: Molecular Mechanisms and Immunologic Aspects. Keystone Symposia, Keystone, Colo. |
| 9. | Maslow, J. N., G. J. Jansen, A. M. Slutsky, E. A. Brown, and R. D. Arbeit. 1994. Phenotypic characterization of a Ca++ and Mg++, and contact dependent hemolysin of Mycobacterium avium, abstr. 24. In Abstracts of the 32nd Annual Meeting of the Infectious Diseases Society of America, 1995. Infectious Diseases Society of America, Washington, D.C. |
| 10. | Nightingale, S. D., L. Byrd, P. Southern, J. Jockusch, S. Cal, and B. Wynne. 1992. Incidence of Mycobacterium avium-intracellulare complex bacteremia in human immunodeficiency virus positive patients. J. Infect. Dis. 165:1082-1085[Medline]. |
| 11. |
Portnoy, D. A.,
T. Chakraborty,
W. Goebel, and P. Cossart.
1992.
Molecular determinants of Listeria monocytogenes pathogenesis.
Infect. Immun.
60:1263-1267 |
| 12. | Prince, D. S., D. D. Peterson, R. M. Steiner, J. E. Gottleib, R. Scott, H. L. Israel, W. G. Figueroa, and J. E. Fish. 1989. Infection with Mycobacterium avium complex in patients without predisposing conditions. N. Engl. J. Med. 321:863-868[Abstract]. |
| 13. |
Saito, H.,
H. Tomioka,
K. Sato,
H. Tasaka,
M. Tsukamura,
F. Kuze, and K. Asano.
1989.
Identification and partial characterization of Mycobacterium avium and Mycobacterium intracellulare by using DNA probes.
J. Clin. Microbiol.
27:994-997 |
| 14. |
Slutsky, A. M.,
R. D. Arbeit,
T. W. Barber,
J. Rich,
C. F. von Reyn,
W. Pieciak,
M. A. Barlow, and J. N. Maslow.
1994.
Polyclonal infection due to Mycobacterium avium complex in patients with AIDS detected by pulsed-field gel electrophoresis of sequential clinical isolates.
J. Clin. Microbiol.
32:1773-1778 |
| 15. | von Reyn, C. F., J. N. Maslow, T. W. Barber, J. O. Falkinham III, and R. D. Arbeit. 1994. Persistent colonization of potable water as a source of Mycobacterium avium infection in AIDS. Lancet 343:1137-1141[Medline]. |
Journal of Clinical Microbiology, February 1999, p. 445-446, Vol. 37, No. 2
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Castellanos, E., Aranaz, A., Gould, K. A., Linedale, R., Stevenson, K., Alvarez, J., Dominguez, L., de Juan, L., Hinds, J., Bull, T. J.
(2009). Discovery of Stable and Variable Differences in the Mycobacterium avium subsp. paratuberculosis Type I, II, and III Genomes by Pan-Genome Microarray Analysis. Appl. Environ. Microbiol.
75: 676-686
[Abstract] [Full Text] -
Prammananan, T., Phunpruch, S., Tingtoy, N., Srimuang, S., Chaiprasert, A.
(2006). Distribution of hsp65 PCR-Restriction Enzyme Analysis Patterns among Mycobacterium avium Complex Isolates in Thailand. J. Clin. Microbiol.
44: 3819-3821
[Abstract] [Full Text] -
Rindi, L., Bonanni, D., Lari, N., Garzelli, C.
(2003). Most Human Isolates of Mycobacterium avium Mav-A and Mav-B Are Strong Producers of Hemolysin, a Putative Virulence Factor. J. Clin. Microbiol.
41: 5738-5740
[Abstract] [Full Text] -
Eckstein, T. M., Belisle, J. T., Inamine, J. M.
(2003). Proposed pathway for the biosynthesis of serovar-specific glycopeptidolipids in Mycobacterium avium serovar 2. Microbiology
149: 2797-2807
[Abstract] [Full Text] -
Beggs, M. L., Stevanova, R., Eisenach, K. D.
(2000). Species Identification of Mycobacterium avium Complex Isolates by a Variety of Molecular Techniques. J. Clin. Microbiol.
38: 508-512
[Abstract] [Full Text]
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»